You are here: Industry Insights > Oxford

News List

Oxford study indicates AstraZeneca’s COVID-19 vaccine woks against Brazil variant: Report expresspharma
March 08, 2021
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the P1, or Brazilian variant, a source with knowledge of the study told Reuters.
Pfizer, Oxford vaccine reduce infection risk in elderly expresspharma
March 03, 2021
Evidence for the Pfizer vaccine suggests that it leads to 83 per cent reduction in deaths from COVID-19.
Genomics plc scores $30m to expand patient-centric health platform pharmatimes
March 02, 2021
Oxford, UK-based Genomics plc has completed a $30m funding round, which the company will use to expand its work on its patient-centric, population health platform.
UK launches trial to study alternating COVID-19 vaccines for different doses europeanpharmaceuticalreview
February 07, 2021
The UK Government has given £7 million of funding for a clinical trial which will investigate whether patients can be given different COVID-19 vaccines for each dose.
AstraZeneca’s first vaccine dose cuts Covid transmission by 67 per cent: Study expresspharma
February 05, 2021
The UK government described this as good news for the world because the impact of COVID vaccines on transmission has been a crucial unknown in the fight against the pandemic.
New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab pharmatimes
February 04, 2021
A primary analysis of late-stage trial data has backed the safety and efficacy of AstraZeneca/Oxford University's COVID-19 vaccine, with 100% protection against severe disease, hospitalisation and death.
Oxford Kept COVID-19 Vaccine Trial Volunteers in Dark About Dosing Error, Letter Shows expresspharma
February 04, 2021
The letter was signed by the trial’s chief investigator, Oxford professor Andrew J. Pollard, and sent to the trial subjects.
AstraZeneca-Oxford COVID-19 vaccine approved in EU expresspharma
February 01, 2021
The AstraZeneca vaccine demonstrated efficacy of around 60 per cent in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement.
UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine expresspharma
December 31, 2020
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March.
AstraZeneca and Oxford-made Covid-19 vaccine not ready for EU market approval pharmaceutical-technology
December 30, 2020
The European Medicines Authority (EMA) has said that the drug maker AstraZeneca and the University of Oxford’s COVID-19 vaccine may not be approved in January next year.

Previous page 1 2 3 4 Next page